Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

External validation of the PALIAR index for patients with advanced, nononcologic chronic diseases

External validation of the PALIAR index for patients with advanced, nononcologic chronic diseases Objective To externally validate the PALIAR index for patients with advanced, nononcologic chronic diseases. Methods We performed a prospective, multicenter cohort study that included patients with advanced, nononcologic chronic diseases hospitalized in internal medicine departments and treated consecutively by the researchers between July 1st and December 31st, 2014. Data were collected from each patient on age, sex, advanced disease, Charlson index, comorbidities, Barthel index, terminal illness symptoms, need for caregiver, hospitalization in the past 3 and 12 months and number of drugs. We calculated the PALIAR index and conducted a 6-month follow-up. To analyze the association between the vari- ables and mortality, we constructed several multivariate logistic regression models. Results The study included 295 patients with a mean age of 82.7 (8.6) years, 148 (50.2%) of whom were women. Mortality at 6 months was associated with the albumin level (OR 0.52, 95% CI 0.30–0.85, p = 0.011), and the terminal illness (OR 2.75, 95% CI 1.55–4.89, p = 0.001). The PALIAR index showed good discrimination for predicting mortality (statistical C, 0.728, 95% CI 0.670–0.787). A reduced version of the PALIAR index showed similar mortality discriminatory power. Conclusions The PALIAR index is a reliable tool for predicting mortality in patients with advanced, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Aging Clinical and Experimental Research Springer Journals

Loading next page...
 
/lp/springer_journal/external-validation-of-the-paliar-index-for-patients-with-advanced-UPZk60qcq6

References (25)

Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Geriatrics/Gerontology
eISSN
1720-8319
DOI
10.1007/s40520-018-0980-3
Publisher site
See Article on Publisher Site

Abstract

Objective To externally validate the PALIAR index for patients with advanced, nononcologic chronic diseases. Methods We performed a prospective, multicenter cohort study that included patients with advanced, nononcologic chronic diseases hospitalized in internal medicine departments and treated consecutively by the researchers between July 1st and December 31st, 2014. Data were collected from each patient on age, sex, advanced disease, Charlson index, comorbidities, Barthel index, terminal illness symptoms, need for caregiver, hospitalization in the past 3 and 12 months and number of drugs. We calculated the PALIAR index and conducted a 6-month follow-up. To analyze the association between the vari- ables and mortality, we constructed several multivariate logistic regression models. Results The study included 295 patients with a mean age of 82.7 (8.6) years, 148 (50.2%) of whom were women. Mortality at 6 months was associated with the albumin level (OR 0.52, 95% CI 0.30–0.85, p = 0.011), and the terminal illness (OR 2.75, 95% CI 1.55–4.89, p = 0.001). The PALIAR index showed good discrimination for predicting mortality (statistical C, 0.728, 95% CI 0.670–0.787). A reduced version of the PALIAR index showed similar mortality discriminatory power. Conclusions The PALIAR index is a reliable tool for predicting mortality in patients with advanced,

Journal

Aging Clinical and Experimental ResearchSpringer Journals

Published: Jun 6, 2018

There are no references for this article.